Effects of Substance P Antagonists on Adrenal Secretion
NCT00977223
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Healthy Volunteers
Interventions
DRUG:
aprepitant/placebo
Sponsor
University Hospital, Rouen